| 000 | 01602 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517043955.0 | ||
| 264 | 0 | _c20160711 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a1878-3279 | ||
| 024 | 7 |
_a10.1016/j.imbio.2015.07.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDorvignit, Denise | |
| 245 | 0 | 0 |
_aAntitumor and cytotoxic properties of a humanized antibody specific for the GM3(Neu5Gc) ganglioside. _h[electronic resource] |
| 260 |
_bImmunobiology _cDec 2015 |
||
| 300 |
_a1343-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _ximmunology |
| 650 | 0 | 4 | _aAntibody Specificity |
| 650 | 0 | 4 | _aAntibody-Dependent Cell Cytotoxicity |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aG(M3) Ganglioside _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIsografts |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 700 | 1 | _aGarcía-Martínez, Liliana | |
| 700 | 1 | _aRossin, Aurélie | |
| 700 | 1 | _aSosa, Katya | |
| 700 | 1 | _aViera, Justo | |
| 700 | 1 | _aHernández, Tays | |
| 700 | 1 | _aMateo, Cristina | |
| 700 | 1 | _aHueber, Anne-Odile | |
| 700 | 1 | _aMesa, Circe | |
| 700 | 1 | _aLópez-Requena, Alejandro | |
| 773 | 0 |
_tImmunobiology _gvol. 220 _gno. 12 _gp. 1343-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.imbio.2015.07.008 _zAvailable from publisher's website |
| 999 |
_c25121884 _d25121884 |
||